Pacira BioSciences, Inc. — Director's Dealing 2011

Jun 6, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2011-06-02

Reporting Person: EVNIN LUKE (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-06-02	Director Stock Option (Right to Buy)	$13.98	A	15692	Acquired	2021-06-02	Common Stock (15692)	Direct

Footnotes

F1: The option vests in twelve equal monthly installments following the vesting commencement date of June 2, 2011.